TRIB2 and acute myeloid leukemia: On the one hand, TRIB2, a pseudokinase, may function as an oncogene and cooperates with HoxA9 to accelerate the onset of AML in mice by binding COP1 and C/EBP-α and leading to degradation of C/EBP-α[31-33].